Oncotelic Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,202 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 126-150 of 768 matching filings.

Per page
25
Current page
6
4

4 filing

Filing date
08 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-258984

S-3/A filing

Filing date
08 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-258984

S-3 filing

Filing date
20 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-21990

10-Q filing

Filing date
20 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
17 Aug 2021
Reporting date
16 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-21990

NT 10-Q filing

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
05 Aug 2021
Reporting date
04 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
20 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
08 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
08 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
02 Jul 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
15 Jun 2021
Reporting date
11 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-256448

424B3 filing

Filing date
03 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-256448

EFFECT filing

Filing date
02 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
01 Jun 2021
Reporting date
25 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .